Pharma & Biotech
The data were presented in detail at the recent American College of Chest Physicians (CHEST) annual meeting
Amryt Pharma cheers orphan designation for pre-clinical skin treatment
Silence Therapeutics completes management team with new chief executive
Oncimmune continues building momentum with partnerships
Only registered members can use this feature.
© Proactive Investors 2020.
Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority. Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.